The Detection of Heat Stress by Assessing Individual Body Responses to Heat (Heat Strain) in Young and Healthy Non-athlete Participants (HEATSTAR)

February 10, 2023 updated by: Noe Brasier, ETH Zurich

HEAT Stress Detection From Personally STandARdized Heat Strain Measurements - The HEATSTAR Pilot Trial

• This study investigates and compares the within and in-between variances of the body responses to different heat stressors in a controlled lab-setting. The participants will be exposed to different heat sources while a variety of physiological heat strain reactions such as heartrate, sweat rate, and core body temperature are recorded using on- and in-body devices. For the participant monitoring during the study, medical grade devices such as a certified ECG and a swallowable sensor-pill to continuously monitor the core body temperature will be applied. A one-for-all wearable device is additionally applied for physiological validation. Further, sweat will be collected to assess (i) the local sweat rate and (ii) the appearance of different heat stress associated molecular markers in this non-invasively collectable biofluid. As a secondary aim, a model will be developed that will enable to predict the different heat stress sources out of the heat strain measurements.

Study Overview

Study Type

Observational

Enrollment (Actual)

23

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Andere (Nicht USA-Länder)
      • Zurich, Andere (Nicht USA-Länder), Switzerland, 8093
        • ETH Zurich

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Participants will be recruited through Swiss Universities and Swiss Universities of Applied Science. The institutions host a broad range of students that are likely to match the inclusion criteria.

Description

Inclusion Criteria:

  • Healthy participant, able to give consent
  • Age 18-40 years
  • Non-athlete (<4h sport/week)
  • BMI<30 (non-obese)
  • German speaking, or fluent in German

Exclusion Criteria:

  • Pregnancy (urine pregnancy test), and breastfeeding
  • Regular medication intake (excluding birth control pill)
  • Intake of drugs and/or daily alcohol consumption
  • Fever or symptoms of an acute infection (cough, shortness of breath, sore throat, taste loss)
  • Active smoking or history of smoking <9 months ago
  • Mobility impairment
  • Traveled (<1 month ago) to a warm/hot temperature zone and stayed for >6 days
  • Any chronic conditions such as: high blood pressure, diabetes mellitus, immuno-deficiencies, sweat disorders such as anhidrosis
  • Color blindness (STROOP test)
  • Weight <40 kg (e-Celsius pill)
  • Diverticulum or obstructions of the gastrointestinal tract (including motility disorders, swallowing disorders) as well as major abdominal surgery (e-Celsius pill)
  • Need of exposure to strong electromagnetic fields during study participation, above all MRI examinations (e-Celsius pill)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Healthy participants
Age of the participants is between 18-40 years, females and males equally distributed
Temporary exposure to increased ambient temperature +10°C (the effect of the intervention is fully and spontaneously reversible)
Temporary exposure to increased ambient relative humidity +40% (max. 90%) (the effect of the intervention is fully and spontaneously reversible)
Temporary exertion on an ergometer (1W/kg body weight) (the effect of the intervention is fully and spontaneously reversible)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The within and between subject heat strain marker variability in relation to specific heat stress sources (ambient heat, ambient humidity, exertion, and clothing)
Time Frame: Max. 7 days
The primary endpoint is the within- and between- subject heat strain marker variability of HR, CBT, WSR, and LSR in relation to various heat stress sources (increased ambient temperature, increased relative humidity, and exertion, all without and with additional clothing.
Max. 7 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Accuracy to detect the specific heat stress source (such as ambient heat, relative humidity) from different on- and in-body measurements
Time Frame: Max. 7 days
The models for the primary endpoints will be extended to explore the relationships between heat strain parameters, heat stress sources, as well as personal characteristics. Additionally, prediction of heat stress source will be explored.
Max. 7 days
Assessment of short-term heart rate variability in context to each heat stressor.
Time Frame: Max. 7 days
Short-term HRV with a repeating time frame of 5min. Root mean square of successive RR interval (RMSSD; in [ms]) and the Standard-deviation of RR intervals (SDRR; in [ms]) will be computed with respect to each heat stress source.
Max. 7 days
Temperature [°C] and relative humidity [%] of the microenvironment as an additional source of information for patterns to detect heat stressors
Time Frame: Max. 7 days
Features of temperature [°C] and relative humidity [%] of the microenvironment as additional model predictors.
Max. 7 days

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
The relation between cognitive assessment and skin temperature
Time Frame: Max. 7 days
Correlation between subjective heat comfort (Visual Analog Scale, where +1 is comfortable and +4 is very uncomfortable) and baseline differential stress inventory (causes of stress, symptoms of stress, coping, stress stabilization) in relation to skin temperature [°C]
Max. 7 days
The relation between STROOP assessment and different heat stressors
Time Frame: Max. 7 days
Correlation between changes in the STROOP assessment outcome (number of errors and time of decision [ms], between beginning and end of heat stress exposure) in context to the various heat stress sources, skin temperature, and thermal comfort.
Max. 7 days
Novel Sweat Biomarkers for heat stress detection
Time Frame: Max. 7 days
Descriptive statistics for novel non-invasive biomarkers from sweat analysis with respect to heat stress source, including between- and within-subject variability
Max. 7 days
Recording heat strain parameters with an all-for-one device
Time Frame: Max. 7 days
The 'reliability' (missing data per minute ([%]) and the 'accuracy' (HR [bpm] with 95% confidence intervals), CBT (in [°C] with 95% confidence intervals), and local sweat rate measurements (in [g/h] with 95% confidence intervals) of the wearable device in recording vital parameters.
Max. 7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

November 2, 2022

Primary Completion (ACTUAL)

January 31, 2023

Study Completion (ACTUAL)

February 10, 2023

Study Registration Dates

First Submitted

November 11, 2022

First Submitted That Met QC Criteria

November 11, 2022

First Posted (ACTUAL)

November 18, 2022

Study Record Updates

Last Update Posted (ACTUAL)

February 13, 2023

Last Update Submitted That Met QC Criteria

February 10, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • EKNZ ID: 2022 - 01325

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heat Stress

Clinical Trials on Elevated ambient heat

Subscribe